These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32034518)

  • 1. Ki67 as a prognostic factor of craniopharyngioma's recurrence in paediatric population.
    Moszczyńska E; Prokop-Piotrkowska M; Bogusz-Wójcik A; Grajkowska W; Szymańska S; Szalecki M
    Childs Nerv Syst; 2020 Jul; 36(7):1461-1469. PubMed ID: 32034518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of P53 protein overexpression, Ki67 proliferative activity and mitotic index as markers of tumour recurrence in superficial transitional cell carcinoma of the bladder.
    Gontero P; Casetta G; Zitella A; Ballario R; Pacchioni D; Magnani C; Muir GH; Tizzani A
    Eur Urol; 2000 Sep; 38(3):287-96. PubMed ID: 10940702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Origin of craniopharyngiomas: implications for growth pattern, clinical characteristics, and outcomes of tumor recurrence.
    Bao Y; Pan J; Qi ST; Lu YT; Peng JX
    J Neurosurg; 2016 Jul; 125(1):24-32. PubMed ID: 26654183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Microenvironment of Primary and Recurrent Craniopharyngiomas: A Study of the Differences and Clinical Significance.
    Lin D; Wang Y; Zhou Z; Lin Z
    World Neurosurg; 2019 Jul; 127():e212-e220. PubMed ID: 30880197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative implantation metastasis of craniopharyngioma: a case report.
    Wang XY; Xu SJ; Li XG
    J Int Med Res; 2010; 38(5):1876-82. PubMed ID: 21309505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craniopharyngioma in children: Marseille experience.
    Lena G; Paz Paredes A; Scavarda D; Giusiano B
    Childs Nerv Syst; 2005 Aug; 21(8-9):778-84. PubMed ID: 16133277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of extra sellar craniopharyngioma masquerading as hypertrophied adenoid tissue in a 6-year-old boy.
    Mohanty S; Balakrishnan S
    Int J Pediatr Otorhinolaryngol; 2008 Sep; 72(9):1441-4. PubMed ID: 18620758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome in children with recurrent craniopharyngioma after primary surgery.
    Kalapurakal JA; Goldman S; Hsieh YC; Tomita T; Marymont MH
    Cancer J; 2000; 6(6):388-93. PubMed ID: 11131489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CD44s Isoform is a Potential Biomarker for Predicting Craniopharyngioma Recurrence in Children.
    Bajdak-Rusinek K; Diak N; Gutmajster E; Fus-Kujawa A; Ciupińska M; Kalina-Faska B; Trybus A; Grajek M; Kalina M; Mandera M
    Neuromolecular Med; 2024 Jul; 26(1):30. PubMed ID: 39020106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Ki67 index a prognostic marker in medullary thyroid carcinoma.
    Tisell LE; Oden A; Muth A; Altiparmak G; Mõlne J; Ahlman H; Nilsson O
    Br J Cancer; 2003 Dec; 89(11):2093-7. PubMed ID: 14647143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between clinical characteristics and proliferative activity in patients with craniopharyngioma.
    Losa M; Vimercati A; Acerno S; Barzaghi RL; Mortini P; Mangili F; Terreni MR; Santambrogio G; Giovanelli M
    J Neurol Neurosurg Psychiatry; 2004 Jun; 75(6):889-92. PubMed ID: 15146007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
    Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
    Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ectopic recurrence of craniopharyngioma: Reporting three new cases.
    Yang Y; Shrestha D; Shi XE; Zhou Z; Qi X; Qian H
    Br J Neurosurg; 2015 Apr; 29(2):295-7. PubMed ID: 25311042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma.
    Wang Y; Deng J; Guo G; Tong A; Peng X; Chen H; Xu J; Liu Y; You C; Zhou L
    J Neurooncol; 2017 Jan; 131(1):21-29. PubMed ID: 27640198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 immunoreactivity in craniopharyngiomas: a clinico-pathological analysis.
    Duò D; Gasverde S; Benech F; Zenga F; Giordana MT
    Clin Neuropathol; 2003; 22(5):229-34. PubMed ID: 14531547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hTERT-protein and Ki-67 labelling index in recurrent and non-recurrent meningiomas.
    Maes L; Lippens E; Kalala JP; de Ridder L
    Cell Prolif; 2005 Feb; 38(1):3-12. PubMed ID: 15679862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
    Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
    Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.
    Tena-Suck ML; Ortiz-Plata A; Galán F; Sánchez A
    Ann Diagn Pathol; 2009 Apr; 13(2):82-8. PubMed ID: 19302955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.
    Foltyn W; Zajęcki W; Marek B; Kajdaniuk D; Siemińska L; Zemczak A; Kos-Kudła B
    Endokrynol Pol; 2012; 63(5):362-6. PubMed ID: 23115069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors for craniopharyngioma recurrence: a systematic review and illustrative case report of a rapid recurrence.
    Prieto R; Pascual JM; Subhi-Issa I; Jorquera M; Yus M; Martínez R
    World Neurosurg; 2013; 79(5-6):733-49. PubMed ID: 22892136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.